Drug specificity, synergy and antagonism in ultrahigh capacity poly (2-oxazoline)/poly (2-oxazine) based formulations
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Polymer micelles offer the possibility to create a nanoscopic environment that is distinct from the bulk phase. They find applications in catalysis, drug delivery, cleaning, etc. Often, one simply distinguishes between hydrophilic and hydrophobic, but fine-tuning of the microenvironment is possible by adjusting the structure of the polymer amphiphile. Here, we investigated a small library of structurally similar amphiphiles based on poly(2-oxazoline)s and poly(2-oxazine)s with respect to their solubilization capacity for two extremely water insoluble drugs, curcumin and paclitaxel. We found very significant and orthogonal specificities even if only one methylene group is exchanged between the polymer backbone and side chain. More strikingly, we observed profound synergistic and antagonistic solubilization patterns for the coformulation of the two drugs. Our findings shed new light on host-guest interaction in polymer micelles and such pronounced host-guest specificities in polymer micelles may not only be interesting in drug delivery but also for applications such as micellar catalysis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“More recently, a variety of POx and poly(2-oxazine) (POzi) based polymers such as poly(2-n-butyl-2-oxazoline) (PBuOx) and poly(2-n-butyl-2-oxazine) (PBuOzi) have gained much attention due to their high loading for physically encapsulating drugs [45, 63, 65].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [63]
In the citing paper
“POx and POzi block copolymers were recently introduced for drug delivery applications and have shown high potential as materials for polymeric micelle drug carriers [45, 63, 111].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [63]
In the citing paper
“Meanwhile, paclitaxel was highly soluble in PMeOx-b-PBuOx-b-PMeOx but is less soluble its POzi analog [63].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [63]
In the citing paper
“Also, a variety of hydrophobic POx blocks have been used to produce micelles with different cores which show differential solubilization profiles with respect to various poorly soluble drugs [63].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [63]
In the citing paper
“This POzi system has an extra carbon in the hydrophobic block backbone compared to the PMeOx-b-PBuOx-b-PMeOx system, and this confers differential solubilizing capacity – the same drug, curcumin, is much less soluble in the POx only system than the POzi polymer.”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [63]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Bioavailability of curcumin: Problems and promises
Anand, P., Kunnumakkara, A. B., Newman, R. A., & Aggarwal, B. B. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700113r · Cited by 5,543
Solvatochromic Dyes as Solvent Polarity Indicators
Reichardt, C. (1994) · Chemical Reviews · doi:10.1021/cr00032a005 · Cited by 5,527
Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer
Dhillon, N., Aggarwal, B. B., Newman, R. A., Wolff, R. A., Kunnumakkara, A. B., Abbruzzese, J. L., Ng, C. S., Badmaev, V., & Kurzrock, R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0024 · Cited by 1,331
Aggarwal, B. B., & Sung, B. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.11.002 · Cited by 1,140
Chemistry: Chemical con artists foil drug discovery
Baell, J., & Walters, M. A. (2014) · Nature · doi:10.1038/513481a · Cited by 1,043
Curcumin—From Molecule to Biological Function
Esatbeyoglu, T., Huebbe, P., Ernst, I. M. A., Chin, D., Wagner, A. E., & Rimbach, G. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201107724 · Cited by 904
Baell, J. B. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b00947 · Cited by 539
Polymer therapeutics-prospects for 21st century: The end of the beginning
Duncan, R., & Vicent, M. J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.08.012 · Cited by 412
Zasadil, L. M., Andersen, K. A., Yeum, D., Rocque, G. B., Wilke, L. G., Tevaarwerk, A. J., Raines, R. T., Burkard, M. E., & Weaver, B. A. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007965 · Cited by 402
Nanoparticles for combination drug therapy
Ma, L., Kohli, M., & Smith, A. (2013) · ACS Nano · doi:10.1021/nn405674m · Cited by 367
Research works printed but not linked: 2
- Ali S., 2012, Am. Pharm. Rev., 15, 1
- Van Krevelen D. W., 2009, Properties of Polymers, 4
Cited by
Items 101–123 of 123
Филиппов, А. П., Kirila, T. Y., Rodchenko, S., Головина, М. А., Козина, Н. Д., & Теньковцев, А. В. (2024) · Nanobiotechnology Reports · doi:10.1134/s2635167624600998 · Cited by 2
Efimova, S. S., Martynyuk, V. A., Козина, Н. Д., Kirila, T. Y., Филиппов, А. П., & Ostroumova, O. S. (2025) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2025.184443 · Cited by 1
Panakkal, V. M., & Sedláček, O. (2025) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2025.106515 · Cited by 1
Kasza, G., Fábián, Á., Fecske, D., Petróczy, A., Horváti, K., & Iván, B. (2026) · ACS Omega · doi:10.1021/acsomega.5c05838 · Cited by 1
Hong, L., Man, R., Chen, X., Yang, Z., Shen, D., & Chen, W. (2026) · Pakistan Journal of Pharmaceutical Sciences · doi:10.36721/pjps.2026.39.6.155.1 · Cited by 1
Penetratin Decoration Increases RNAi Silencing Effects of Polymeric Carriers
Drago, S. E., Cabibbo, M., Scialabba, C., Craparo, E. F., & Cavallaro, G. (2026) · Chemistry of Materials · doi:10.1021/acs.chemmater.6c00522 · Cited by 1
“1 H NMR PMeOx-Pip-Boc (300 MHz, CDCl 3 , 25 ° C, TMS) δ : The BOC protecting group was removed in acidic medium as already reported, 30,48 and the recover product product, obtained with an approximate yield of 98% (w/w based on the starting polymer), was characterized by 1 H NMR analysis and SEC…”
InfluentialLiang, F., Wang, M., Hu, Y., Guo, Z., & Yang, W. (2022) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2022.128250 · Cited by 1
Kirila, T. Y., Razina, A. B., Теньковцев, А. В., & Филиппов, А. П. (2022) · Polymer Science Series C · doi:10.1134/s1811238222700102 · Cited by 1
Филиппов, А. П., Blokhin, A. N., Головина, М. А., Kirila, T. Y., Козина, Н. Д., Rodchenko, S., & Теньковцев, А. В. (2025) · Russian Chemical Bulletin · doi:10.1007/s11172-024-4668-x · Cited by 1
Kirila, T. Y., Rodchenko, S., Козина, Н. Д., Теньковцев, А. В., & Филиппов, А. П. (2026) · Chinese Journal of Polymer Science · doi:10.1007/s10118-025-3490-8 · Cited by 1
Verbraeken, B. (2018) · Ghent University Academic Bibliography (Ghent University) · Cited by 1
Lübtow, M. M., Lorson, T., Finger, T., Gröber‐Becker, F., & Luxenhofer, R. (2019) · ChemRxiv · doi:10.26434/chemrxiv.8280761.v1 · Cited by 1
Self-citationAdvances in Thermoresponsive Polymers
Sponchioni, M. (2022) · MDPI eBooks · doi:10.3390/books978-3-0365-4011-5
Lübtow, M. M., Lorson, T., Finger, T., Gröber‐Becker, F., & Luxenhofer, R. (2019) · ChemRxiv · doi:10.26434/chemrxiv.8280761
Self-citationSmirnova, A. V., Теньковцев, А. В., & Филиппов, А. П. (2022) · Polymer Science Series C · doi:10.1134/s1811238222700072
Advances in Cationic Ring-opening Polymerization of Cyclic Imino Ethers
Pattyn, E., Jana, S., & Hoogenboom, R. (2026) · Elsevier eBooks · doi:10.1016/b978-0-323-95486-0.00210-6
Thananukul, K., Buachi, C., Srimai, C., Niyomsin, S., Rutnakornpituk, M., Sunintaboon, P., Tighe, B. J., Derry, M. J., Topham, P. D., Molloy, R., et al. (2026) · ACS Omega · doi:10.1021/acsomega.6c02331
Reproducibility and Batch-Dependent Variability in Polymer-Based Nanocarriers
Ziegler, A., Ziegler, F. T., Lusiani, N., Perera, L., Flouri, E. C., Helbig, L.-S., Takmakova, E., Sedláček, O., Dargaville, T. R., & Luxenhofer, R. (2026) · ACS Nano Medicine · doi:10.1021/acsnanomed.6c00192
Self-citationMicelles in cancer nanomedicine: targeted delivery, imaging, and therapy
Rashnoodi, A., Seraj, Z., Zamani, N., & Najafabad, B. K. (2026) · Academia Drug Development and Pharmacotherapy · doi:10.20935/acaddrug8458
Nanomedicine beyond carriers — devices, cells & living therapeutics
Grattoni, A., Paci, M. M., Arnold, N., Aryal, S., Artzi, N., Bao, G., Barcena, A. J. R., Bentov‐Arava, E., Blanco, E., Chua, C. Y. X., et al. (2026) · Biomedical Microdevices · doi:10.1007/s10544-026-00836-8
“Kabanov, Luxenhofer and Jordan significantly advanced the field by developing high-drug-loaded POx and POzi polymer micelles, PMs, for diverse therapeutic agents (Hwang et al. 2020; Kabanov et al. 2016; Lubtow et al. 2017; Luxenhofer et al. 2010).”
Jana, S., & Hoogenboom, R. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115975
Maichl, D. S., Cheng, W.-H., Kumari, P., Kirner, J. A., Schmidt, S., Ade, C. P., Yang, M., Haider, M. S., Chi, Y., Luxenhofer, R., et al. (2026) · Biomarker Research · doi:10.1186/s40364-026-01018-7
“…nanoformulations with exceptional properties including ultra-high drug loading and excellent cyto-and biocompatibility have been generated [35, 47, 48, 62], and have been excellently tolerated following in vivo administration, either intravenously, intraperitoneally, or subcutaneously [63, 64].”
Self-citationHaider, M. S., & Luxenhofer, R. (2026) · Biomacromolecules · doi:10.1021/acs.biomac.6c01970
Self-citation
Metadata
- Authors
- Lübtow, M. M., Hahn, L., Haider, M. S., & Luxenhofer, R.
- Affiliations
- University of Würzburg (DE)
- Corresponding author
- Luxenhofer, Robert
- Venue
- Journal of the American Chemical Society
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-08-08
- Volume
- 139
- Issue
- 32
- Pages
- 10980-10983
- ISSN
- 0002-7863 (ISSN-L)
- 1520-5126
- OpenAlex
- W2741222691
- Cited by
- 120
- References
- 37
- Citations by year
- 2026: 12 · 2025: 10 · 2024: 11 · 2023: 12 · 2022: 11 · 2021: 17 · 2020: 15 · 2019: 21 · 2018: 10 · 2017: 1
- FWCI
- 5.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of the American Chemical Society (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutscher Akademischer Austauschdienst
- Higher Education Commission, Pakistan
- Evonik Stiftung
- Topics
- Physical Sciences › Chemistry › Physical and Theoretical Chemistry › Surfactants and Colloidal Systems
- Physical Sciences › Chemistry › Organic Chemistry › Advanced Polymer Synthesis and Characterization
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- polymeric micelles, poly(2-oxazoline), amphiphilic molecules, drug solubilization, curcumin, paclitaxel, host-guest interactions, drug synergy, drug antagonism, drug delivery, micellar catalysis, poorly water-soluble drugs
- MeSH terms
- Antineoplastic Agents, Curcumin, Drug Carriers, Micelles, Oxazines, Oxazoles, Solubility, Surface-Active Agents, Water, Paclitaxel
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.